Dr. Ciccolini on Residual Concentrations of Cetuximab in Head and Neck Cancer - OncLive

OncLive

Dr. Ciccolini on Residual Concentrations of Cetuximab in Head and Neck Cancer OncLive There have been tools to improve the way existing treatments work for patients with head and neck cancer, explains Ciccolini. To achieve this, changes were made with the doses or the scheduling of the sequences to improve the efficacy or limit the ... and more »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nd2yPR
via IFTTT